≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Toxic effect of carbon monoxide

MESH Endpoint Browser

ST19_TOXIC_EFFECT_CARBON_MONOX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T58
  • Cause of death: ICD-10 — T58

2 out of 7 registries used, show all original rules.

628

4. Check minimum number of events

None

628

5. Include endpoints

None

628

6. Filter based on genotype QC (FinnGen only)

628

Control definitions (FinnGen only)

Control exclude
ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T5[1-9]|T6[0-5]
Name in latin
Effectus toxicus monoxidi carbonei

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 628 289 339
Unadjusted period prevalence (%) 0.13 0.10 0.15
Median age at first event (years) 54.33 53.89 54.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
552
Matched controls
5518
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T58
ICD-10 Finland
Toxic effect of carbon monoxide
4503599627370496.0
323.0
548
*
X09
ICD-10 Finland
Exposure to unspecified smoke, fire and flames
436.3
108.3
105
*
X47
ICD-10 Finland
Accidental poisoning by and exposure to carbon monoxide and other gases and vapours
+∞
94.5
88
*
X00
ICD-10 Finland
Exposure to uncontrolled fire in building or structure
232.5
42.5
43
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
10.9
29.7
58
59
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.0
27.4
64
89
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.0
25.8
88
201
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
9.5
16.7
34
38
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
6.7
16.4
42
67
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.6
16.2
35
43
N07BB01
ATC
disulfiram; oral
4.8
16.1
55
125
N05AH04
ATC
quetiapine; oral
2.7
15.8
123
532
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
10.1
14.9
29
30
N03AG01
ATC
valproic acid; systemic, rectal
4.3
14.7
56
142
F10.20
ICD-10 Finland
Alcohol dependence currently independent
7.6
14.2
33
46
N05AH03
ATC
olanzapine; systemic
4.0
14.0
58
159
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
13.3
132
645
AA1AD
NOMESCO Finland
CT of head and brain
2.3
13.2
149
773
X14
ICD-10 Finland
Contact with hot air and gases
41.1
13.2
16
*
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
10.9
11.8
22
21
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
11.5
102
467
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
11.5
11.1
20
18
P29
ICPC
Psychological sympt/compl other
3.9
11.1
46
127
N05AA02
ATC
levomepromazine; systemic
4.4
11.1
40
97
N06AX11
ATC
mirtazapine; oral
2.0
11.1
183
1106
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
10.8
62
220
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
10.7
85
365
N06AB03
ATC
fluoxetine; oral
2.6
10.5
79
332
X03
ICD-10 Finland
Exposure to controlled fire, not in building or structure
+∞
10.4
10
*
P15
ICPC
Chronic alcohol abuse
4.7
10.2
34
76
SPAT1263
SPAT
Sampling
1.8
10.2
243
1660
N06AB04
ATC
citalopram; systemic
2.1
10.2
122
645
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.0
10.1
27
47
N05BA04
ATC
oxazepam; oral
2.0
9.9
141
800
X58
ICD-10 Finland
Exposure to other specified factors
2.3
9.7
94
448
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
56.0
9.7
11
*
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
56.0
9.7
11
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.3
9.6
22
31
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
9.5
180
1131
N05BA01
ATC
diazepam; systemic, rectal
2.5
9.5
80
355
S06.0
ICD-10 Finland
Concussion
2.5
9.2
71
302
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
9.3
9.1
18
20
SPAT1254
SPAT
Administration of medicine
2.3
9.1
92
449
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
12.8
8.9
15
12
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
8.8
163
1010
X84
ICD-10 Finland
Intentional self-harm by unspecified means
50.8
8.7
10
*
SPAT1240
SPAT
Therapeutic discussion
2.5
8.7
70
303
SPAT1301
SPAT
No procedures
1.8
8.6
179
1156
M79.6
ICD-10 Finland
Pain in limb
1.8
8.5
184
1200
R51.80
ICD-10 Finland
Headache
2.3
8.5
82
390
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
13.0
8.4
14
11
N05AF03
ATC
chlorprothixene; systemic
4.8
8.4
27
59
T51.0
ICD-10 Finland
Toxic effect: Ethanol
+∞
8.3
8
*
F02.89*T58
ICD-10 Finland
Dementia with carbon monoxide intoxication
+∞
8.3
8
*
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
14.7
8.2
13
9
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
8.2
62
261
SPAT1265
SPAT
Breathalyser
9.1
8.1
16
18
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
8.1
229
1617
N05AD01
ATC
haloperidol; systemic
4.7
8.0
26
58
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
6.7
7.9
19
29
P16
ICPC
Acute alcohol abuse
6.7
7.9
19
29
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
8.6
7.9
16
19
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
10.2
7.6
14
14
K29.2
ICD-10 Finland
Alcoholic gastritis
81.1
7.4
8
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
7.3
41
142
F10.24
ICD-10 Finland
Alcohol depence active use
5.6
7.3
20
37
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
7.2
46
175
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.3
7.2
34
106
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.5
7.2
16
22
ZXH09
SPAT
NA
5.4
7.1
20
38
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.7
7.1
19
34
N03AX09
ATC
lamotrigine; oral
3.3
7.0
33
103
B01AC04
ATC
clopidogrel; oral
2.0
7.0
86
456
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
14.0
6.9
11
8
ZYC01
SPAT
NA
2.9
6.8
40
146
Y94.8
ICD-10 Finland
Other leisure activity accident
4.8
6.8
21
45
N05CF01
ATC
zopiclone; oral
1.7
6.6
158
1051
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
6.6
89
486
N05AX08
ATC
risperidone; systemic
2.5
6.6
49
204
SPAT1101
SPAT
Orthostatic test
3.4
6.6
30
92
Z03
ICPC
Housing/neighbourhood problem
10.2
6.6
12
12
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
6.4
75
390
SPAT1104
SPAT
Monitoring of emergency patient
2.7
6.4
41
157
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
6.4
211
1528
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.2
6.3
31
101
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.3
94
537
S18
ICPC
Laceration/cut
1.6
6.3
210
1525
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
27.0
6.2
8
*
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
27.0
6.2
8
*
V03AA01
ATC
NA
5.1
6.2
18
36
R42
ICD-10 Finland
Dizziness and giddiness
1.8
6.2
107
641
P72
ICPC
Schizophrenia
5.4
6.2
17
32
N05BA02
ATC
chlordiazepoxide; systemic
4.1
6.2
22
55
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
6.1
49
213
F60.2
ICD-10 Finland
Dissocial personality disorder
12.7
6.1
10
8
P01
ICPC
Feeling anxious/nervous/tense
2.2
6.1
59
283
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.1
127
807
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.6
6.1
43
176
WW200
SPAT
NA
2.2
6.0
61
297

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019060) Gas panel - Arterial blood
155
318
6.14
75.50
2.9
6.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
111
179
7.32
68.29
2.6
4.0
mmol/l
1.4
1.4
0.10
111
174
(3003396) Base excess in Arterial blood by calculation
188
552
4.43
58.79
4.3
8.5
mmol/l
1.1
1.1
0.08
142
437
(3002173) Hemoglobin [Mass/volume] in Arterial blood
170
462
4.67
58.76
4.2
9.4
g/l
129.2
121.5
4.07
165
446
(3020891) Body temperature
99
188
6.06
51.36
3.8
4.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
231
1088
2.78
31.28
4.8
3.8
kg/l
1.0
1.0
1.27
30
150
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
320
1882
2.43
26.07
4.7
3.6
ng/l
55.4
39.5
0.57
233
1288
(3028707) Methadone [Presence] in Urine by Screen method
49
96
5.45
24.20
8.5
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
422
2884
2.41
23.41
5.7
4.8
mmol/l
6.7
6.7
0.03
404
2676
(3000991) Gas panel - Venous blood
108
396
3.09
22.49
5.4
8.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
338
2140
2.25
21.92
5.8
6.0
mmol/l
1.2
1.2
3.33
321
1938
(3029937) Albumin [Presence] in Urine by Test strip
237
1320
2.28
20.72
4.4
3.8
estimate
0.0
0.0
0.69
54
459
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
264
1558
2.20
19.83
3.2
2.5
u/l
56.4
57.9
0.28
248
1454
(3002032) Base excess in Venous blood by calculation
111
445
2.82
19.54
3.3
3.5
mmol/l
2.2
1.9
0.32
97
348
(1001926) Buprenorphine [Presence] in Urine by Screen method
60
174
3.71
18.03
7.7
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
345
2346
2.04
16.99
6.6
6.8
mmol/l
1.2
1.2
1.96
296
1997
(3016879) Cocaine [Presence] in Urine
65
208
3.37
16.81
7.5
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
365
2574
2.00
15.76
6.0
6.3
umol/l
9.7
11.5
5.21
353
2442
(3020191) Ethanol [Moles/volume] in Serum or Plasma
26
43
6.26
15.23
2.8
1.4
promille
1.9
1.3
1.01
19
35
(3027008) Opiates [Presence] in Urine
65
224
3.12
14.87
7.4
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
65
224
3.12
14.87
7.5
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
290
1925
1.94
14.57
4.4
3.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
50
148
3.58
14.56
9.7
3.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
65
227
3.08
14.54
8.1
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
291
1948
1.92
14.12
7.7
9.0
inr
1.2
1.2
0.18
69
581
(3027944) Amphetamines [Presence] in Urine
63
223
3.03
13.76
5.3
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
233
1459
1.95
13.72
2.7
2.1
u/l
172.5
277.2
1.32
224
1376
(3011397) Hemoglobin [Presence] in Urine by Test strip
186
1081
2.02
13.54
4.5
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
239
1533
1.90
12.93
4.7
3.1
mmol/l
7.4
8.2
1.91
211
1287
(40761535) Cells panel - Urine sediment
91
403
2.47
12.88
3.8
3.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
339
2473
1.81
11.78
4.0
3.5
estimate
0.0
0.0
0.00
55
453
(3024561) Albumin [Mass/volume] in Serum or Plasma
293
2050
1.80
11.68
4.4
4.8
g/l
35.7
35.8
0.08
285
1921
(3021601) Nitrite [Presence] in Urine by Test strip
335
2443
1.80
11.58
5.0
4.7
estimate
0.0
0.0
0.00
55
473
(3035350) Ketones [Presence] in Urine by Test strip
334
2435
1.79
11.54
4.2
3.4
estimate
0.0
0.0
0.00
55
470
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
113
582
2.15
11.17
11.2
7.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
63
257
2.61
10.54
5.9
11.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
205
1325
1.81
10.36
4.2
4.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
351
2.36
10.17
2.7
2.5
ml/min/173m2
57.9
66.3
1.04
26
152
(4198724)
16
25
6.54
9.85
2.9
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
189
1210
1.80
9.77
2.2
2.0
mg/l
3.1
3.1
0.03
170
1030
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
462
3812
1.80
9.49
7.9
7.4
u/l
77.0
77.6
0.13
453
3578
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
207
1374
1.76
9.40
2.8
3.1
ng/l
1489.1
1279.7
0.22
193
1167
(3013650) Neutrophils [#/volume] in Blood by Automated count
368
2855
1.70
9.39
9.8
9.0
e9/l
4.6
4.1
2.58
339
2518
(3019309) Folate [Moles/volume] in Red Blood Cells
145
876
1.85
8.96
1.9
1.7
nmol/l
1313.2
1155.0
1.61
119
665
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
13
18
7.35
8.87
2.0
1.6
umol/l
57.7
79.1
—
6
9
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
66
301
2.33
8.70
1.6
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
450
3731
1.73
8.55
4.1
3.8
pmol/l
14.7
14.8
0.22
421
3381
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
120
692
1.91
8.54
4.0
1.8
%
1.9
1.5
3.64
98
618
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
569
5095
2.24
8.27
18.0
13.5
mg/l
23.3
23.7
0.10
501
3999
(3022217) INR in Platelet poor plasma by Coagulation assay
107
600
1.94
8.26
16.9
23.3
inr
1.3
1.3
0.20
20
81
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
304
2293
1.63
8.24
4.3
4.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
119
3.06
8.21
1.9
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
26
73
3.67
8.20
4.1
5.0
umol/l
363.9
353.1
0.15
21
63
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
156
995
1.76
7.95
1.7
1.7
pmol/l
448.4
8859650.6
0.50
134
824
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
24
5.94
7.88
1.7
1.8
—
1224630.0
—
0
5
(3031040) Bacteria [#/volume] in Urine by Automated count
397
3225
1.63
7.75
4.7
4.2
e6/l
295.5
1997.4
—
6
45
(3023520) Reticulocytes [#/volume] in Blood
77
394
2.09
7.65
2.3
2.7
e9/l
69.0
71.5
0.28
63
308
(3012095) Magnesium [Moles/volume] in Serum or Plasma
127
771
1.81
7.63
2.7
3.3
mmol/l
0.8
0.8
0.35
122
727
(3021960) Folate [Moles/volume] in Serum or Plasma
171
1132
1.70
7.59
1.5
1.6
nmol/l
18.5
20.4
0.89
158
971
(3015377) Calcium [Moles/volume] in Serum or Plasma
220
1568
1.62
7.28
2.7
3.3
mmol/l
2.3
2.4
0.34
202
1388
(4034850)
40
158
2.64
7.16
10.4
9.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
33
4.63
6.49
2.1
4.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
70
3.37
6.47
1.8
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
196
1392
1.59
6.44
3.6
4.0
ph
7.4
7.4
1.17
39
258
(3019198) Lymphocytes [#/volume] in Blood
321
2546
1.53
6.43
5.8
5.8
e9/l
1.9
1.9
0.00
299
2269
(3001604) Monocytes [#/volume] in Blood
312
2463
1.53
6.37
5.6
5.7
e9/l
0.6
0.6
0.20
287
2147
(3044889) 12 lead EKG panel
414
3480
1.56
6.29
4.5
3.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
313
2480
1.52
6.23
5.7
5.7
e9/l
0.0
0.0
0.03
289
2169
(3007853) Bacteria identified in Skin by Aerobe culture
97
580
1.80
6.06
1.9
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
430
3666
1.55
5.95
4.5
4.0
mm/h
12.7
11.3
1.12
413
3387
(3012516) Albumin [Mass/volume] in Urine
194
1397
1.56
5.92
3.5
3.3
mg/l
60.7
249.3
1.34
157
918
(4010399)
64
337
2.00
5.89
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
112
710
1.70
5.70
2.1
2.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
318
2561
1.49
5.66
6.1
6.0
e9/l
0.2
0.2
0.25
297
2278
(3027945) Reticulocytes/100 erythrocytes in Blood
91
545
1.78
5.65
2.4
2.7
%
1.7
1.8
0.27
79
493
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
249
1913
1.50
5.56
2.0
2.0
pmol/l
89.8
94.4
1.09
146
1035
(3017143) Hepatitis C virus Ab [Presence] in Serum
102
644
1.70
5.25
1.8
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
136
1905
0.63
5.17
2.7
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
125
840
1.61
5.04
1.7
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
272
2163
1.45
4.95
3.2
2.7
ug/l
131.3
137.6
0.17
257
2000
(3020682) Albumin/Creatinine [Ratio] in Urine
199
1490
1.49
4.92
4.3
4.0
mg/mmol
8.8
10.0
0.22
157
963
(40760892) CBC W Ordered Manual Differential panel - Blood
158
1128
1.54
4.89
4.9
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
118
788
1.61
4.88
2.0
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
510
4630
1.54
4.29
6.4
5.6
mmol/mol
39.9
39.8
0.07
491
4323
(3017569) Oxygen content in Arterial blood
12
31
3.93
4.27
2.1
4.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
47
251
1.94
4.20
7.0
10.1
mmol/l
24.1
24.4
0.25
42
235
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
503
4562
1.52
4.16
5.0
4.4
mu/l
1.9
2.4
0.74
481
4191
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
134
956
1.51
4.11
4.4
3.6
ng/l
247.5
413.3
0.56
101
738
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
545
1.62
3.89
2.1
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
179
1372
1.43
3.77
3.1
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
395
3454
1.39
3.76
4.6
4.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
109
759
1.53
3.73
2.4
2.4
umol/l
12.9
13.3
0.22
102
702
(1616796) Gas panel - Central venous blood
23
98
2.40
3.61
3.7
3.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
214
1704
1.39
3.59
4.2
3.3
u/l
29.7
32.6
1.34
204
1626
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
81
541
1.57
3.34
2.0
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
118
860
1.46
3.22
2.4
3.1
mmol/l
2.4
2.4
0.17
108
757
(40768804) Tissue Pathology biopsy report
149
1907
0.71
3.21
1.9
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
215
1741
1.36
3.18
3.1
3.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
164
1273
1.39
3.15
2.6
2.7
umol/l
347.3
6413.6
4.63
148
1103
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
174
1.95
3.11
2.5
3.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
29
3.49
3.06
2.4
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
394
3511
1.33
2.94
4.6
3.1
u/l
58.5
48.9
1.30
369
3307
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
41
2.96
2.87
2.1
1.1
nmol/l
1.4
1.4
0.01
12
36
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
148
1147
1.38
2.85
2.4
2.3
—
—
—
0
0
(3010421) pH of Blood
25
123
2.08
2.85
4.0
3.9
ph
7.4
7.4
0.59
16
100
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
55
348
1.64
2.85
3.2
3.5
ng/l
73.9
83.3
0.57
49
311
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
36
3.09
2.82
1.7
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
303
1.67
2.77
3.9
3.0
mmol/l
1.3
1.7
0.21
37
224
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
523
4886
1.42
2.75
5.2
4.3
mmol/l
6.1
6.0
1.90
495
4481
(3024928) Oxygen saturation in Venous blood
21
98
2.18
2.73
5.3
3.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
220
1.77
2.71
5.0
3.5
mmol/l
24.7
24.2
0.41
30
198
(3009343) pH of Capillary blood
51
322
1.64
2.67
3.9
2.9
ph
7.4
7.4
—
8
37
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
108
804
1.41
2.63
1.3
1.3
iu/ml
41.0
35.0
0.18
33
267
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
141
1102
1.36
2.56
1.9
1.7
mg/l
0.9
1.2
1.34
110
839
(3017509) Phencyclidine [Presence] in Urine
5
7
7.19
2.55
2.4
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
33
3.06
2.53
1.5
1.5
%
13.5
11.5
—
10
33
(40761511) CBC panel - Blood by Automated count
564
5364
1.50
2.50
18.5
12.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
444
4767
0.77
2.35
19.1
14.1
%
39.7
40.5
0.87
273
3520
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
103
779
1.39
2.29
1.4
1.3
u/ml
13.6
11.6
0.12
50
312
(3044640) Blood type and Crossmatch panel - Blood
184
1522
1.30
2.23
2.4
2.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
203
1.71
2.22
1.7
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.3
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.3
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.3
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
37
578
0.62
2.17
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
229
1955
1.27
2.15
2.3
2.2
nmol/l
71.1
75.7
1.62
216
1756
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
1030
1.33
2.15
1.9
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
126
994
1.33
2.14
2.4
2.6
e6/l
6.9
5.7
0.28
114
870
(3016244) Insulin [Units/volume] in Serum or Plasma
9
31
2.93
2.08
5.2
2.1
mu/l
40.4
17.8
—
9
31
(3007461) Platelets [#/volume] in Blood
593
5732
1.62
2.07
28.4
19.7
e9/l
249.2
246.4
0.48
587
5586
(40758558) Short blood count panel - Blood
148
1201
1.30
2.06
7.4
6.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
593
5736
1.61
2.02
28.3
19.7
e12/l
4.5
4.5
3.78
587
5577
(1002224) Polysomnography panel
11
243
0.44
2.00
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
70
2.17
1.99
1.3
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
593
5738
1.60
1.99
28.4
19.7
e9/l
7.1
6.7
3.81
587
5578
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
77
2.11
1.98
1.1
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
566
5433
1.42
1.90
12.7
10.0
u/l
27.0
27.6
0.38
557
5248
(4035726)
24
403
0.58
1.89
1.8
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
100
1.93
1.87
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
486
0.62
1.86
1.6
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
47
322
1.50
1.80
1.5
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
85
1093
0.74
1.79
2.6
2.8
ug/l
0.6
0.8
1.18
53
676
(3035637) Corticotropin [Mass/volume] in Plasma
11
47
2.36
1.78
1.6
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
87
668
1.35
1.78
2.5
2.4
%
20.9
23.3
0.71
65
576
(1761482) Bacteria [#/volume] in Urine by Culture
5
136
0.36
1.77
8.0
4.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
416
1.43
1.77
1.7
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
147
1.73
1.76
1.6
1.5
ug/g
208.5
294.6
1.33
13
88
(3017181) Myelocytes/100 leukocytes in Blood
58
418
1.43
1.73
3.5
4.5
%
1.6
0.9
0.59
24
131
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
243
1.56
1.72
2.2
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
89
1.94
1.71
1.3
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
172
1.66
1.70
2.1
2.5
u/l
6342.1
1253.1
—
7
68
(3001019) Free T4 and TSH panel - Serum or Plasma
13
253
0.50
1.70
1.8
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
346
1.45
1.63
1.7
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
14
3.59
1.62
2.4
2.0
umol/l
10.9
17.8
—
5
14
(3022313) Gas panel - Capillary blood
35
231
1.55
1.61
4.4
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
191
1.60
1.60
1.6
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
85
1.91
1.56
2.3
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
142
0.42
1.54
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
21
2.87
1.51
14.5
10.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
116
1.75
1.50
1.4
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
599
0.70
1.49
4.2
4.3
%
31.4
31.5
0.01
33
409
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
37
2.45
1.48
1.6
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
9
37
2.45
1.48
1.1
1.3
%
43.9
31.5
—
9
26
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
38
2.39
1.46
1.4
1.4
nmol/l
18.2
21.0
—
9
32
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
66
1.99
1.44
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
66
1.99
1.44
1.2
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
260
2330
1.20
1.42
6.5
6.1
%
8.5
8.6
0.30
252
2198
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
53
2.09
1.39
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
54
2.06
1.33
1.3
1.7
pg
32.4
33.4
0.18
11
54
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
83
1.83
1.32
1.3
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
98
802
1.26
1.29
2.3
2.7
e6/l
1.6
1.0
0.83
68
450
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
18
2.79
1.28
2.2
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
18
2.79
1.28
2.2
3.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
257
2320
1.18
1.26
6.2
5.8
%
2.7
2.9
0.75
246
2171
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
531
5109
1.25
1.26
5.2
4.7
mmol/l
2.7
2.8
1.55
499
4724
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
110
916
1.24
1.25
1.7
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
139
1.60
1.24
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
11
202
0.54
1.24
4.3
3.6
u/ml
432.5
6746.1
0.70
11
174
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
56
1.98
1.22
1.3
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
37
2.18
1.21
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
37
264
1.43
1.21
1.5
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
101
1.70
1.21
1.3
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
17
101
1.70
1.21
4.8
4.2
mmol/l
1.6
2.6
—
10
63
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
117
1.64
1.19
1.4
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
64
1.89
1.18
1.3
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
50
378
1.35
1.18
3.2
3.8
mmol/l
1.2
1.2
0.60
45
333
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
50
2.02
1.17
1.0
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
87
1.74
1.16
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
68
540
1.29
1.15
1.6
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
248
2248
1.17
1.14
6.1
5.9
%
0.7
0.7
0.28
239
2109
(21494890) Protein electrophoresis panel - 24 hour Urine
8
40
2.01
1.12
1.4
3.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.2
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.2
2.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
159
1394
1.19
1.08
3.2
3.1
—
—
—
0
0
(44806118)
11
59
1.88
1.08
1.5
1.6
—
—
—
0
0
(44790049)
11
59
1.88
1.08
1.5
1.6
—
—
—
0
0
(44790048)
11
59
1.88
1.08
1.5
1.6
—
—
—
0
0
(44790047)
11
59
1.88
1.08
1.5
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
262
2396
1.16
1.06
6.4
6.0
%
27.4
27.9
0.30
250
2249
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
82
1.72
1.06
1.3
2.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
259
2368
1.16
1.05
6.3
5.7
%
58.0
57.0
0.69
249
2235
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
22
2.28
1.03
1.2
2.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
83
1.70
1.02
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
91
1.66
1.01
2.9
2.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
48
1.89
1.00
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
18
115
1.58
1.00
1.6
1.2
mg/l
475.4
473.6
0.01
18
109
(4094501)
7
134
0.52
0.99
1.3
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
520
5024
1.20
0.99
4.6
4.3
mmol/l
4.5
4.6
2.09
489
4677
(21494755) Public health laboratory ask at order entry panel
46
589
0.76
0.98
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
329
0.69
0.98
1.5
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
12
69
1.75
0.97
1.1
1.0
g/l
1.6
1.5
0.45
12
62
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
564
1.25
0.95
1.4
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
101
1.60
0.94
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
232
0.64
0.93
4.3
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
74
613
1.23
0.91
1.8
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
146
1291
1.17
0.90
2.9
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
78
652
1.22
0.89
1.3
1.3
titre
852.3
440.6
0.54
13
132
(40768797) Stomach Pathology biopsy report
78
654
1.22
0.87
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
44
1.83
0.86
1.1
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
187
1692
1.15
0.85
3.3
3.7
e6/l
83.5
111.2
0.26
147
1195
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
31
1.94
0.84
1.2
3.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
137
0.58
0.84
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
49
391
1.27
0.84
3.9
4.7
%
0.3
0.2
0.47
20
119
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
139
0.57
0.84
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
89
1.59
0.81
1.1
1.1
u/ml
4.5
2.9
—
6
33
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
66
1.68
0.79
1.8
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
179
1624
1.14
0.78
6.2
5.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
126
0.55
0.78
1.1
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
149
1337
1.15
0.76
2.9
3.0
e6/l
0.5
0.4
0.12
120
1000
(3025159) Blasts/100 leukocytes in Blood
46
370
1.26
0.75
4.0
4.7
%
0.0
0.2
0.94
16
101
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
125
1110
1.16
0.74
1.3
1.2
u/ml
3.2
1.6
0.28
45
319
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
582
1.21
0.74
2.3
2.7
umol/l
5.4
8.8
2.87
62
513
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
21
150
1.41
0.74
2.9
1.8
pmol/l
222.3
225.7
0.05
21
142
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
108
1.49
0.74
4.1
4.1
mg/l
16.3
23.9
1.18
11
70
(4027681)
5
25
2.01
0.73
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
5
25
2.01
0.73
2.2
1.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
309
1.28
0.72
3.2
2.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
514
4997
1.16
0.71
4.5
4.2
mmol/l
1.4
1.4
1.56
481
4626
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.4
1.6
nmol/l
1.1
1.0
—
5
20
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
2.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
41
1.72
0.70
1.7
2.1
—
1.1
—
0
5
(3033658) Prothrombin time (PT) actual/Normal
134
1202
1.15
0.70
3.9
3.7
%
92.1
89.8
0.47
127
1183
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
135
1.42
0.69
2.7
2.4
u/ml
0.3
0.3
0.04
12
72
(3025941) Bacteria identified in Stool by Culture
38
302
1.27
0.69
1.5
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
77
1.57
0.69
1.0
1.0
u/ml
2.3
10.4
—
6
39
(3035320) C reactive protein [Mass/volume] in Body fluid
5
27
1.86
0.68
5.8
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
157
1426
1.13
0.68
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
162
1.37
0.67
1.5
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
488
1.21
0.65
3.7
3.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
201
0.69
0.65
3.4
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
120
1.43
0.65
1.4
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
66
769
0.84
0.64
2.7
2.8
e6/l
3.6
2.1
0.38
37
422
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
129
0.62
0.64
2.1
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
46
379
1.23
0.63
4.0
4.4
%
0.9
0.5
0.54
15
94
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
13
87
1.50
0.63
1.4
1.2
u/l
39.7
19.8
0.35
13
76
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
15
104
1.45
0.63
1.6
1.2
mmol/l
3.6
3.8
0.26
15
98
(40768800) Prostate Pathology biopsy report
6
104
0.57
0.62
1.3
1.2
—
—
—
0
0
(44813793)
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
51
1.58
0.60
1.5
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(4211845)
0
22
0.00
0.59
0.0
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
485
1.19
0.58
2.5
4.5
ug/l
13.9
35.4
0.58
51
407
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
8
53
1.52
0.58
1.0
1.0
—
1.3
—
0
11
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
114
0.61
0.58
1.3
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
35
1.72
0.58
2.7
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
35
285
1.24
0.55
1.9
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
27
213
1.28
0.55
1.2
1.5
—
10.1
—
0
5
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
60
1.51
0.54
2.7
5.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
170
0.70
0.54
1.2
2.0
g/l
3.4
3.8
—
7
121
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
170
0.70
0.54
1.2
2.0
g/l
6.9
7.4
—
7
128
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
170
0.70
0.54
1.2
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
159
1468
1.11
0.53
3.0
3.2
e6/l
32.3
117.2
1.08
132
1123
(36660697) Celiac disease serology panel - Serum
45
379
1.20
0.52
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
482
1.18
0.52
2.9
2.2
nmol/l
11.4
13.7
1.28
51
436
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
64
1.41
0.51
1.1
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
86
960
0.88
0.50
2.6
2.7
mosm/kgh2o
529.6
564.8
0.85
74
818
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
111
0.63
0.48
1.3
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
111
0.63
0.48
1.3
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
46
1.53
0.48
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
44
515
0.84
0.48
1.8
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
128
1.34
0.48
1.5
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
47
1.49
0.47
1.1
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
48
1.46
0.47
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
117
0.68
0.46
1.4
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
350
3374
1.08
0.45
2.9
3.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
69
1.46
0.44
1.4
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
9
128
0.70
0.43
2.3
2.1
%
201.3
187.6
—
9
122
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3013512) EKG study
152
1418
1.09
0.42
4.3
3.8
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
15
0.00
0.41
0.0
1.2
—
394.7
—
0
9
(40765096) Chromosome analysis panel by Banding
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
4.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
0.7
—
0
8
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
1.0
—
0
10
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
1.4
1.3
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
18
0.00
0.40
0.0
1.1
—
25.7
—
0
13
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
25
205
1.23
0.40
2.7
1.8
nmol/l
36.4
38.4
0.26
25
196
(40768793) Breast Pathology biopsy report
7
102
0.68
0.40
1.4
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
105
0.66
0.39
1.1
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
19
0.00
0.39
0.0
1.3
—
1.1
—
0
12
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
170
0.76
0.38
1.5
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
36
1.39
0.38
4.8
2.1
e6/l
585.8
493.9
—
5
30
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
493
4838
1.09
0.36
4.2
3.8
mmol/l
1.4
1.3
3.42
461
4469
(3037121) Protein [Mass/volume] in Urine
14
179
0.78
0.36
3.6
3.4
g/l
0.2
0.2
—
8
70
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
78
0.64
0.36
1.2
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
135
1.27
0.35
3.5
3.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
43
1.40
0.35
1.5
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
312
1.16
0.34
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
160
1513
1.08
0.33
4.6
4.0
%
19.6
21.3
1.07
73
664
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
266
1.17
0.33
1.4
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
132
0.75
0.32
3.9
2.7
mg/l
1.6
1.5
—
10
120
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
156
1.22
0.31
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
52
1.35
0.31
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
54
1.30
0.30
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
56
1.25
0.29
1.6
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
658
0.90
0.29
1.6
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
121
1.25
0.28
1.8
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
308
1.14
0.28
1.2
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
158
1.21
0.28
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
63
1.27
0.28
1.4
2.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
64
1.25
0.27
1.5
1.3
nmol/l
0.5
0.5
—
8
57
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
19
160
1.19
0.25
1.4
1.5
g/l
1.1
1.2
0.33
19
152
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
73
1.24
0.25
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
83
0.72
0.24
1.0
1.2
—
—
—
0
0
(4024509)
5
38
1.32
0.23
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
162
1.18
0.23
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
162
1.18
0.23
1.4
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
91
0.77
0.22
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
91
0.77
0.22
1.1
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
146
0.82
0.22
1.3
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
72
672
1.08
0.22
1.9
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
135
1.19
0.21
1.9
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
137
1313
1.06
0.20
1.7
1.6
mmol/l
1.6
1.4
1.06
119
1111
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
18
155
1.17
0.20
1.4
1.5
g/l
0.2
0.2
0.48
18
147
(3021589) Normoblasts [#/volume] in Blood
226
2195
1.05
0.20
10.2
9.1
e9/l
0.0
0.0
0.61
198
1812
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
99
1.22
0.19
2.1
6.6
—
204.5
—
0
17
(3000034) Microalbumin [Mass/volume] in Urine
6
53
1.13
0.18
3.3
3.2
mg/l
7.4
19.0
—
6
40
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
28
253
1.11
0.17
1.1
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
66
0.76
0.17
1.6
2.5
mmol/l
104.8
105.5
—
5
66
(3041354) Potassium [Moles/volume] in Venous blood
5
66
0.76
0.17
1.6
2.5
mmol/l
4.3
4.0
—
5
66
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
173
0.86
0.17
1.4
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
92
1.20
0.16
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
87
0.80
0.14
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
87
0.80
0.14
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
88
0.79
0.14
2.4
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
93
1.19
0.14
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
65
617
1.06
0.14
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
122
1.15
0.14
1.9
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
96
0.83
0.14
1.8
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
170
1.12
0.13
1.4
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
110
0.82
0.13
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
221
0.90
0.13
2.4
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
324
0.92
0.13
1.1
1.2
iu/ml
94.5
147.0
—
10
128
(3017732) Neutrophils [#/volume] in Blood
33
354
0.93
0.12
2.8
2.8
e9/l
4.3
4.1
0.23
28
281
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
19
172
1.11
0.11
1.2
1.4
miu/ml
200.7
261.5
—
5
82
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
135
0.89
0.10
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
135
0.89
0.10
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
135
0.89
0.10
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
135
0.89
0.10
1.3
1.5
—
—
—
0
0
(4146454)
5
46
1.09
0.09
2.0
2.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
27
252
1.07
0.09
2.5
2.9
e6/l
0.3
0.2
0.14
27
243
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
48
1.04
0.09
1.0
1.1
—
196.7
—
0
9
(3023410) Appearance of Cerebral spinal fluid
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
55
1.09
0.09
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
57
1.05
0.08
1.0
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
6
58
1.03
0.08
1.2
1.3
mu/l
34.6
56.6
—
6
53
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
63
0.79
0.08
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
65
0.77
0.08
1.6
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
117
1.11
0.08
2.3
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
67
1.05
0.08
1.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
68
1.03
0.08
1.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
68
1.03
0.08
1.1
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
82
0.85
0.07
1.0
1.1
—
11.0
—
0
5
(3007164) IgA [Mass/volume] in Serum or Plasma
97
993
0.97
0.07
1.5
1.4
g/l
2.3
2.5
0.45
68
627
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
163
0.92
0.07
1.4
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
13
142
0.91
0.06
1.7
4.2
mg/l
48.8
98.8
—
6
115
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
13
142
0.91
0.06
1.7
4.2
mg/l
33.7
34.7
—
5
116
(3023511) Choriogonadotropin [Units/volume] in Urine
9
100
0.90
0.06
1.6
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
105
0.86
0.06
1.2
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
54
557
0.97
0.06
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
100
1.10
0.05
1.8
5.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
120
0.92
0.05
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
51
524
0.97
0.04
1.2
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
142
1.06
0.02
1.5
2.3
mg/l
9.2
11.6
0.91
15
131
(3048689) Calprotectin [Mass/mass] in Stool
65
642
1.01
0.01
1.9
2.4
ug/g
131.3
121.7
0.15
53
517
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
106
0.94
0.01
1.2
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
166
1.02
0.00
1.6
1.7
—
163.3
—
0
6
(40768443) Skin Pathology biopsy report
19
194
0.98
0.00
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
107
1.03
0.00
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
197
1.02
0.00
1.4
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
42
423
0.99
0.00
4.0
3.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
20
198
1.01
0.00
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
47
473
0.99
0.00
3.2
2.3
u/l
38.3
43.3
0.19
42
410
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
111
0.99
0.00
1.3
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
209
1.00
0.00
1.4
1.8
mg/l
3.8
3.8
0.00
16
150
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
251
1.00
0.00
1.5
1.5
—
—
—
0
0
(3019225) pH of Specimen
46
459
1.00
0.00
4.6
4.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
82
0.98
0.00
4.5
3.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
189
1890
1.00
0.00
4.6
4.5
ug/l
2.9
2.4
0.21
174
1710
(3012441) Differential panel - Pleural fluid
5
51
0.98
0.00
1.0
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
5
52
0.96
0.00
1.0
1.3
e6/l
1931.0
1752.7
—
5
38
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
2.1
—
0
9
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
1.0
—
0
7
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
475
4750
1.00
0.00
13.9
12.4
ml/min/173m2
84.3
83.1
0.47
393
3902
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
89
0.90
0.00
2.1
3.7
%
51.5
57.9
—
8
89
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
9.2
—
0
6
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
68
0.88
0.00
1.2
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.2
—
0
5
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
71
0.99
0.00
1.4
3.1
u/ml
15.2
32.8
—
7
71
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
68
0.88
0.00
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
67
0.89
0.00
1.2
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
59
1.02
0.00
2.3
2.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
110.2
—
0
5
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
72
0.97
0.00
2.3
2.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
52
0.96
0.00
3.2
2.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
78
0.90
0.00
1.4
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
87
0.92
0.00
1.9
3.3
e9/l
3.2
4.4
—
8
87
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
70.1
—
0
7
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
75
0.93
0.00
1.6
3.3
—
3114.7
—
0
9
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_TOXIC_EFFECT_CARBON_MONOX – Toxic effect of carbon monoxide

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).